JP2009509661A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009509661A5 JP2009509661A5 JP2008533552A JP2008533552A JP2009509661A5 JP 2009509661 A5 JP2009509661 A5 JP 2009509661A5 JP 2008533552 A JP2008533552 A JP 2008533552A JP 2008533552 A JP2008533552 A JP 2008533552A JP 2009509661 A5 JP2009509661 A5 JP 2009509661A5
- Authority
- JP
- Japan
- Prior art keywords
- vaso
- factor
- occlusion
- occlusive
- occlusive device
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003795 chemical substances by application Substances 0.000 claims 7
- 239000000463 material Substances 0.000 claims 7
- 230000000975 bioactive Effects 0.000 claims 5
- 206010053648 Vascular occlusion Diseases 0.000 claims 4
- 210000004204 Blood Vessels Anatomy 0.000 claims 3
- 239000004744 fabric Substances 0.000 claims 3
- 239000000835 fiber Substances 0.000 claims 3
- 239000002861 polymer material Substances 0.000 claims 3
- 108010061932 Factor VIIIa Proteins 0.000 claims 2
- 108010074864 Factor XI Proteins 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 229920000728 polyester Polymers 0.000 claims 2
- 239000005020 polyethylene terephthalate Substances 0.000 claims 2
- 229920000642 polymer Polymers 0.000 claims 2
- -1 polysiloxane Polymers 0.000 claims 2
- 229920001059 synthetic polymer Polymers 0.000 claims 2
- 230000002885 thrombogenetic Effects 0.000 claims 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims 2
- GYDJEQRTZSCIOI-LJGSYFOKSA-N (1r,4r)-4-(aminomethyl)cyclohexane-1-carboxylic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 claims 1
- NKCXQMYPWXSLIZ-PSRDDEIFSA-N (2S)-2-[[(2S)-1-[(2S)-5-amino-2-[[2-[[(2S)-6-amino-2-[[2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-amino-3-hydroxybutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-hydroxybutanoyl]amino]propanoyl]amino]-4-oxobutanoyl]amino]-3-m Chemical compound O=C([C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)O)C(C)C)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O NKCXQMYPWXSLIZ-PSRDDEIFSA-N 0.000 claims 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N Aminocaproic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 claims 1
- 108010039627 Aprotinin Proteins 0.000 claims 1
- 101700026049 CCN2 Proteins 0.000 claims 1
- 102100020540 CCN2 Human genes 0.000 claims 1
- 102000008186 Collagen Human genes 0.000 claims 1
- 108010035532 Collagen Proteins 0.000 claims 1
- 229920000742 Cotton Polymers 0.000 claims 1
- 229920004934 Dacron® Polymers 0.000 claims 1
- 101700033006 EGF Proteins 0.000 claims 1
- 102000016942 Elastin Human genes 0.000 claims 1
- 108010014258 Elastin Proteins 0.000 claims 1
- 102100015239 F2 Human genes 0.000 claims 1
- 102100009906 F7 Human genes 0.000 claims 1
- 102100006624 F9 Human genes 0.000 claims 1
- 101710003421 FGF Proteins 0.000 claims 1
- 101700033323 FGF7 Proteins 0.000 claims 1
- 108010076282 Factor IX Proteins 0.000 claims 1
- 108010048049 Factor IXa Proteins 0.000 claims 1
- 108010014172 Factor V Proteins 0.000 claims 1
- 108010023321 Factor VII Proteins 0.000 claims 1
- 108010054265 Factor VIIa Proteins 0.000 claims 1
- 229940012414 Factor VIIa Drugs 0.000 claims 1
- 108010074105 Factor Va Proteins 0.000 claims 1
- 108010014173 Factor X Proteins 0.000 claims 1
- 108010071289 Factor XIII Proteins 0.000 claims 1
- 108010074860 Factor Xa Proteins 0.000 claims 1
- 108010049003 Fibrinogen Proteins 0.000 claims 1
- 229940012952 Fibrinogen Drugs 0.000 claims 1
- 102000008946 Fibrinogen Human genes 0.000 claims 1
- 229940019698 Fibrinogen containing hemostatics Drugs 0.000 claims 1
- 108010088842 Fibrinolysin Proteins 0.000 claims 1
- 102000016359 Fibronectins Human genes 0.000 claims 1
- 108010067306 Fibronectins Proteins 0.000 claims 1
- ZPNFWUPYTFPOJU-LPYSRVMUSA-N Iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 claims 1
- 108010002352 Interleukin-1 Proteins 0.000 claims 1
- 108010002350 Interleukin-2 Proteins 0.000 claims 1
- 108090001005 Interleukin-6 Proteins 0.000 claims 1
- 108090001007 Interleukin-8 Proteins 0.000 claims 1
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 claims 1
- 102000007547 Laminin Human genes 0.000 claims 1
- 108010085895 Laminin Proteins 0.000 claims 1
- 239000004677 Nylon Substances 0.000 claims 1
- 229940012957 Plasmin Drugs 0.000 claims 1
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 claims 1
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 claims 1
- 108010094028 Prothrombin Proteins 0.000 claims 1
- 229940039716 Prothrombin Drugs 0.000 claims 1
- 101700038204 TGFA Proteins 0.000 claims 1
- 101710040537 TNF Proteins 0.000 claims 1
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N Tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 claims 1
- 108090000190 Thrombin Proteins 0.000 claims 1
- 102000004887 Transforming Growth Factor beta Human genes 0.000 claims 1
- 108090001012 Transforming Growth Factor beta Proteins 0.000 claims 1
- 102000006747 Transforming growth factor alpha Human genes 0.000 claims 1
- 102100015249 VEGFA Human genes 0.000 claims 1
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 claims 1
- 210000002268 Wool Anatomy 0.000 claims 1
- 229960002684 aminocaproic acid Drugs 0.000 claims 1
- 239000000504 antifibrinolytic agent Substances 0.000 claims 1
- 229960004405 aprotinin Drugs 0.000 claims 1
- 229920003235 aromatic polyamide Polymers 0.000 claims 1
- 239000004202 carbamide Substances 0.000 claims 1
- 101710014509 celF Proteins 0.000 claims 1
- 229960005188 collagen Drugs 0.000 claims 1
- 229920001436 collagen Polymers 0.000 claims 1
- 229920002549 elastin Polymers 0.000 claims 1
- 229960004222 factor IX Drugs 0.000 claims 1
- 229940012413 factor VII Drugs 0.000 claims 1
- 229940012426 factor X Drugs 0.000 claims 1
- 229940012444 factor XIII Drugs 0.000 claims 1
- 230000003352 fibrogenic Effects 0.000 claims 1
- 230000037320 fibronectin Effects 0.000 claims 1
- 239000002657 fibrous material Substances 0.000 claims 1
- 102000006495 integrins Human genes 0.000 claims 1
- 108010044426 integrins Proteins 0.000 claims 1
- 239000004745 nonwoven fabric Substances 0.000 claims 1
- 229920001778 nylon Polymers 0.000 claims 1
- 230000000896 plasminic Effects 0.000 claims 1
- 229920002239 polyacrylonitrile Polymers 0.000 claims 1
- 229920000139 polyethylene terephthalate Polymers 0.000 claims 1
- 229920000098 polyolefin Polymers 0.000 claims 1
- 229920001296 polysiloxane Polymers 0.000 claims 1
- 229920003288 polysulfone Polymers 0.000 claims 1
- 229920002635 polyurethane Polymers 0.000 claims 1
- 239000004814 polyurethane Substances 0.000 claims 1
- 125000005373 siloxane group Chemical group [SiH2](O*)* 0.000 claims 1
- 229960004072 thrombin Drugs 0.000 claims 1
- 229960000401 tranexamic acid Drugs 0.000 claims 1
- 239000002759 woven fabric Substances 0.000 claims 1
Claims (18)
- 血管閉塞装置において、
少なくとも1つのポリマー材料を備えている少なくとも1つの閉塞要素であって、前記少なくとも1つの閉塞要素の少なくとも表面は、前記少なくとも1つのポリマー材料で被覆されており、前記少なくとも1つのポリマー材料は、少なくとも部分的に少なくとも1つのバイオ活性剤(bioactive agent)が詰まっている複数の穴を有している、閉塞要素を備えており、
前記少なくとも1つのバイオ活性剤は、患者の血管の閉塞を促進し、該血管閉塞装置は、前記患者の血管を閉塞するように構成されている、血管閉塞装置。 - 前記少なくとも1つの閉塞要素の少なくとも一部分は、前記少なくとも1つのポリマー材料で作られている、請求項1に記載の血管閉塞装置。
- 前記少なくとも1つの閉塞要素は、実質的に、前記少なくとも1つのポリマー材料で作られている、請求項1に記載の血管閉塞装置。
- 少なくとも1つのバイオ活性剤は、血栓形成性、線維形成性、抗血栓溶解性、又は抗線維素溶解性の薬剤である、請求項1に記載の血管閉塞装置。
- 少なくとも1つのバイオ活性剤は、プラスミン、トロンビン、プロトロンビン、フィブリノゲン、因子V、因子Va、因子VII、因子VIIa、因子VIII、因子VIIIa、因子IX、因子IXa、因子X、因子Xa、因子XI、因子XIa、因子Xii、XIIa、因子XIII、vWF、アミノカプロン酸、アプロチニン、トラネキサム酸、desopressin、エタンシラート、インテグリン、アルギニン−グリシン−アスパラギン酸残基含有ペプチド、コラーゲン、エラスティン、フィブロネクチン、ラミニン、vitroneetin、ホモシステイン、CTGF、VEGF、PDGF、FGF、KGF、TNF、EGF、TGF−α、TGF−β、IL−1、IL−2、IL−6、及びIL−8から成るグループから選択される、請求項4に記載の血管閉塞装置。
- 吸収可能剤(resorbable agent)を更に有している、請求項1に記載の血管閉塞装置。
- 前記少なくとも1つの閉塞要素は、血管を閉塞するように構成されている三次元構造を有する空間充填構造要素である、請求項1に記載の血管閉塞装置。
- 前記少なくとも1つの空間充填構造要素は、コイル、糸、又は繊維、又はそれらの組み合わせである、請求項7に記載の血管閉塞装置。
- 前記少なくとも1つの閉塞要素は、1つ又は複数の空間充填構造要素を囲い込んでいる、拡張可能な閉塞袋である、請求項1に記載の血管閉塞装置。
- 前記少なくとも1つの閉塞要素は、少なくとも1つの空間充填材料を囲い込んでいる、拡張可能な閉塞袋である、請求項1に記載の血管閉塞装置。
- 前記少なくとも1つのポリマー材料は、ポリエステル、フッ化ポリマー、ポリシロキサン、ポリウレタン、ポリオレフィン、ポリアクリロニトリル、ナイロン、ポリアラミド、及びポリスルホンで構成されているグループから選択されたポリマーを備えている、請求項1に記載の血管閉塞装置。
- 前記少なくとも1つのポリマー材料は、ポリエーテルウレタンウレアと、シロキサンを含む表面修飾剤(surface modifying agent)と、を含んでいる、請求項1に記載の血管閉塞装置。
- 前記少なくとも1つのポリマー材料は、THORALONを含んでいる、請求項12に記載の血管閉塞装置。
- 前記少なくとも1つのポリマー材料は、織布、不織布、及び編んだ布地から成るグループから選択される、複数の繊維を有する布地を含んでいる、請求項1に記載の血管閉塞装置。
- 前記複数の繊維の内の少なくとも1つは、複数の穴を含有しており、前記複数の穴の内の少なくとも幾つかは、少なくとも部分的には少なくとも1つのバイオ活性剤が詰められている、請求項14に記載の血管閉塞装置。
- 前記布地は、合成ポリマーを含んでいる、請求項14に記載の血管閉塞装置。
- 前記合成ポリマーは、ポリエチレンテレフタレートである、請求項16に記載の血管閉塞装置。
- 前記閉塞要素の少なくとも表面は、DACRON、綿、絹、羊毛、ポリエステル、及びそれらの組み合わせから成るグループから選択された血栓形成繊維材料を備えている、請求項1に記載の血管閉塞装置。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72236005P | 2005-09-30 | 2005-09-30 | |
US60/722,360 | 2005-09-30 | ||
PCT/US2006/037595 WO2007041131A2 (en) | 2005-09-30 | 2006-09-28 | Coated vaso-occlusion device |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2009509661A JP2009509661A (ja) | 2009-03-12 |
JP2009509661A5 true JP2009509661A5 (ja) | 2009-11-12 |
JP5063603B2 JP5063603B2 (ja) | 2012-10-31 |
Family
ID=37697592
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008533552A Active JP5063603B2 (ja) | 2005-09-30 | 2006-09-28 | 被覆された血管閉塞装置 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20070082021A1 (ja) |
EP (2) | EP1931265B1 (ja) |
JP (1) | JP5063603B2 (ja) |
AT (1) | ATE536140T1 (ja) |
WO (1) | WO2007041131A2 (ja) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6632241B1 (en) | 2000-03-22 | 2003-10-14 | Endovascular Technologies, Inc. | Self-expanding, pseudo-braided intravascular device |
US20060178697A1 (en) * | 2005-02-04 | 2006-08-10 | Carr-Brendel Victoria E | Vaso-occlusive devices including non-biodegradable biomaterials |
US20070142859A1 (en) * | 2005-12-19 | 2007-06-21 | Boston Scientific Scimed, Inc. | Embolic coils |
EP1992371A1 (de) * | 2007-05-15 | 2008-11-19 | Occlutech GmbH | Bioresorbierbare röntgenopake Polymermaterialien und daraus hergestellte Occlussionsinstrumente |
US20090099591A1 (en) | 2007-10-15 | 2009-04-16 | Boston Scientific Scimed, Inc. | Coil Anchor Systems and Methods of Use |
EP2259809B1 (en) * | 2008-02-29 | 2016-05-25 | Cook Biotech Incorporated | Coated embolization device |
EP2467172A1 (en) | 2009-08-10 | 2012-06-27 | Osseous Technologies Of America | Self-supporting collagen tunnel for guided tissue regeneration and method of using same |
EP2422823B1 (en) * | 2010-07-30 | 2014-03-19 | Institut Quimic De Sarria | Bioactive implant |
AU2011298843A1 (en) * | 2010-09-06 | 2013-04-04 | Nonwotecc Medical Gmbh | Device for closing openings or cavities in blood vessels |
US8795319B2 (en) | 2011-03-02 | 2014-08-05 | Cook Medical Technologies Llc | Embolization coil |
US20130035665A1 (en) * | 2011-08-05 | 2013-02-07 | W. L. Gore & Associates, Inc. | Polymer-Based Occlusion Devices, Systems and Methods |
JP5853632B2 (ja) * | 2011-11-22 | 2016-02-09 | 国立大学法人京都大学 | モデル動物、モデル動物の作製方法及び体内留置具の評価方法 |
US10342548B2 (en) * | 2012-01-13 | 2019-07-09 | W. L. Gore & Associates, Inc. | Occlusion devices and methods of their manufacture and use |
US9277905B2 (en) | 2012-08-02 | 2016-03-08 | W. L. Gore & Associates, Inc. | Space-filling device |
US9788842B2 (en) * | 2013-03-06 | 2017-10-17 | St. Jude Medical, Cardiology Division, Inc. | PMVR clip configurations for mitral leaflet |
WO2016086050A1 (en) * | 2014-11-24 | 2016-06-02 | Boston Scientific Scimed, Inc. | Nitinol occlusion plug |
EP3265024B9 (en) * | 2015-03-02 | 2022-02-16 | Accurate Medical Therapeutics Ltd. | Preventing non-target embolization |
ES2833377T3 (es) * | 2015-06-04 | 2021-06-15 | Endomagnetics Ltd | Materiales marcadores y formas de localizar un marcador magnético |
US10736638B2 (en) * | 2015-10-07 | 2020-08-11 | Boston Scientific Scimed, Inc. | Method of applying hemostatic or tissue healing agent to wet surfaces |
JP7126882B2 (ja) * | 2018-07-04 | 2022-08-29 | 株式会社アルバック | 生体適合膜の形成方法、および、生体適合膜の形成装置 |
CN109464168B (zh) * | 2018-12-17 | 2020-09-29 | 先健科技(深圳)有限公司 | 封堵器 |
Family Cites Families (86)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3772137A (en) * | 1968-09-30 | 1973-11-13 | Du Pont | Polyester pillow batt |
CA962021A (en) | 1970-05-21 | 1975-02-04 | Robert W. Gore | Porous products and process therefor |
US4675361A (en) | 1980-02-29 | 1987-06-23 | Thoratec Laboratories Corp. | Polymer systems suitable for blood-contacting surfaces of a biomedical device, and methods for forming |
US4861830A (en) | 1980-02-29 | 1989-08-29 | Th. Goldschmidt Ag | Polymer systems suitable for blood-contacting surfaces of a biomedical device, and methods for forming |
US4473665A (en) * | 1982-07-30 | 1984-09-25 | Massachusetts Institute Of Technology | Microcellular closed cell foams and their method of manufacture |
US5017664A (en) * | 1987-06-03 | 1991-05-21 | Wisconsin Alumni Research Foundation | Biocompatible polyurethane devices wherein polyurethane is modified with lower alkyl sulfonate and lower alkyl carboxylate |
US5160674A (en) | 1987-07-29 | 1992-11-03 | Massachusetts Institute Of Technology | Microcellular foams of semi-crystaline polymeric materials |
US5024671A (en) | 1988-09-19 | 1991-06-18 | Baxter International Inc. | Microporous vascular graft |
US4994069A (en) | 1988-11-02 | 1991-02-19 | Target Therapeutics | Vaso-occlusion coil and method |
IL90193A (en) * | 1989-05-04 | 1993-02-21 | Biomedical Polymers Int | Polurethane-based polymeric materials and biomedical articles and pharmaceutical compositions utilizing the same |
US5122136A (en) * | 1990-03-13 | 1992-06-16 | The Regents Of The University Of California | Endovascular electrolytically detachable guidewire tip for the electroformation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas |
US5108407A (en) | 1990-06-08 | 1992-04-28 | Rush-Presbyterian St. Luke's Medical Center | Method and apparatus for placement of an embolic coil |
US5217484A (en) | 1991-06-07 | 1993-06-08 | Marks Michael P | Retractable-wire catheter device and method |
US5122132A (en) | 1991-08-01 | 1992-06-16 | Bremer Medical, Inc. | Skull pin with enhanced shear resistance |
US5226911A (en) * | 1991-10-02 | 1993-07-13 | Target Therapeutics | Vasoocclusion coil with attached fibrous element(s) |
US5234437A (en) * | 1991-12-12 | 1993-08-10 | Target Therapeutics, Inc. | Detachable pusher-vasoocclusion coil assembly with threaded coupling |
US5261916A (en) | 1991-12-12 | 1993-11-16 | Target Therapeutics | Detachable pusher-vasoocclusive coil assembly with interlocking ball and keyway coupling |
EP0630432B1 (en) * | 1992-03-13 | 1999-07-14 | Atrium Medical Corporation | Controlled porosity expanded fluoropolymer (e.g. polytetrafluoroethylene) products and fabrication |
DK0637323T3 (da) * | 1992-04-24 | 1999-05-25 | Polymer Technology Group Inc | Copolymerer og ikke-porøs, semipermeabel membran deraf og dens anvendelse til permeering af molekyler med et forudbestemt m |
US5589563A (en) * | 1992-04-24 | 1996-12-31 | The Polymer Technology Group | Surface-modifying endgroups for biomedical polymers |
WO1994006460A1 (en) * | 1992-09-21 | 1994-03-31 | Vitaphore Corporation | Embolization plugs for blood vessels |
US5312415A (en) | 1992-09-22 | 1994-05-17 | Target Therapeutics, Inc. | Assembly for placement of embolic coils using frictional placement |
US5250071A (en) | 1992-09-22 | 1993-10-05 | Target Therapeutics, Inc. | Detachable embolic coil assembly using interlocking clasps and method of use |
US5275826A (en) | 1992-11-13 | 1994-01-04 | Purdue Research Foundation | Fluidized intestinal submucosa and its use as an injectable tissue graft |
US5334210A (en) * | 1993-04-09 | 1994-08-02 | Cook Incorporated | Vascular occlusion assembly |
US5735892A (en) | 1993-08-18 | 1998-04-07 | W. L. Gore & Associates, Inc. | Intraluminal stent graft |
US5554389A (en) * | 1995-04-07 | 1996-09-10 | Purdue Research Foundation | Urinary bladder submucosa derived tissue graft |
US6774278B1 (en) * | 1995-06-07 | 2004-08-10 | Cook Incorporated | Coated implantable medical device |
US6168622B1 (en) * | 1996-01-24 | 2001-01-02 | Microvena Corporation | Method and apparatus for occluding aneurysms |
US5792154A (en) * | 1996-04-10 | 1998-08-11 | Target Therapeutics, Inc. | Soft-ended fibered micro vaso-occlusive devices |
PL331765A1 (en) | 1996-08-23 | 1999-08-02 | Cook Biotech Inc | Trnsplant prosthesis, materials and methods |
US5855618A (en) * | 1996-09-13 | 1999-01-05 | Meadox Medicals, Inc. | Polyurethanes grafted with polyethylene oxide chains containing covalently bonded heparin |
AU743779B2 (en) | 1996-12-10 | 2002-02-07 | Cook Biotech, Inc. | Tubular grafts from purified submucosa |
US6099567A (en) * | 1996-12-10 | 2000-08-08 | Purdue Research Foundation | Stomach submucosa derived tissue graft |
US6096052A (en) * | 1998-07-08 | 2000-08-01 | Ovion, Inc. | Occluding device and method of use |
US5733329A (en) * | 1996-12-30 | 1998-03-31 | Target Therapeutics, Inc. | Vaso-occlusive coil with conical end |
US5993844A (en) * | 1997-05-08 | 1999-11-30 | Organogenesis, Inc. | Chemical treatment, without detergents or enzymes, of tissue to form an acellular, collagenous matrix |
US5928260A (en) * | 1997-07-10 | 1999-07-27 | Scimed Life Systems, Inc. | Removable occlusion system for aneurysm neck |
US6156061A (en) * | 1997-08-29 | 2000-12-05 | Target Therapeutics, Inc. | Fast-detaching electrically insulated implant |
US6159165A (en) * | 1997-12-05 | 2000-12-12 | Micrus Corporation | Three dimensional spherical micro-coils manufactured from radiopaque nickel-titanium microstrand |
US8177743B2 (en) * | 1998-05-18 | 2012-05-15 | Boston Scientific Scimed, Inc. | Localized delivery of drug agents |
US6572650B1 (en) | 1998-06-05 | 2003-06-03 | Organogenesis Inc. | Bioengineered vascular graft support prostheses |
US5980550A (en) * | 1998-06-18 | 1999-11-09 | Target Therapeutics, Inc. | Water-soluble coating for bioactive vasoocclusive devices |
US6652581B1 (en) * | 1998-07-07 | 2003-11-25 | Boston Scientific Scimed, Inc. | Medical device with porous surface for controlled drug release and method of making the same |
US6187024B1 (en) * | 1998-11-10 | 2001-02-13 | Target Therapeutics, Inc. | Bioactive coating for vaso-occlusive devices |
US6569179B2 (en) * | 1998-11-10 | 2003-05-27 | Scimed Life Systems, Inc. | Bioactive three loop coil |
US8016852B2 (en) * | 1998-11-10 | 2011-09-13 | Stryker Corporation | Bioactive components for incorporation with vaso-occlusive members |
DK1051116T3 (da) * | 1998-12-01 | 2009-02-02 | Univ Washington | Emboliseringsanordning |
US6280457B1 (en) * | 1999-06-04 | 2001-08-28 | Scimed Life Systems, Inc. | Polymer covered vaso-occlusive devices and methods of producing such devices |
US6663607B2 (en) * | 1999-07-12 | 2003-12-16 | Scimed Life Systems, Inc. | Bioactive aneurysm closure device assembly and kit |
US6790228B2 (en) * | 1999-12-23 | 2004-09-14 | Advanced Cardiovascular Systems, Inc. | Coating for implantable devices and a method of forming the same |
US7014645B2 (en) * | 1999-10-04 | 2006-03-21 | Microvention Inc. | Method of manufacturing expansile filamentous embolization devices |
US6238403B1 (en) * | 1999-10-04 | 2001-05-29 | Microvention, Inc. | Filamentous embolic device with expansible elements |
US6702849B1 (en) * | 1999-12-13 | 2004-03-09 | Advanced Cardiovascular Systems, Inc. | Method of processing open-celled microcellular polymeric foams with controlled porosity for use as vascular grafts and stent covers |
US6391037B1 (en) * | 2000-03-02 | 2002-05-21 | Prodesco, Inc. | Bag for use in the intravascular treatment of saccular aneurysms |
EP1142535B1 (en) * | 2000-04-07 | 2012-10-03 | Collagen Matrix, Inc. | Embolization device |
US6530934B1 (en) * | 2000-06-06 | 2003-03-11 | Sarcos Lc | Embolic device composed of a linear sequence of miniature beads |
US6821295B1 (en) * | 2000-06-26 | 2004-11-23 | Thoratec Corporation | Flared coronary artery bypass grafts |
US7153323B1 (en) * | 2000-06-30 | 2006-12-26 | Boston Scientific Scimed, Inc. | Aneurysm liner with multi-segment extender |
US6939377B2 (en) * | 2000-08-23 | 2005-09-06 | Thoratec Corporation | Coated vascular grafts and methods of use |
US7077859B2 (en) * | 2000-12-22 | 2006-07-18 | Avantec Vascular Corporation | Apparatus and methods for variably controlled substance delivery from implanted prostheses |
US20020082620A1 (en) * | 2000-12-27 | 2002-06-27 | Elaine Lee | Bioactive materials for aneurysm repair |
US6547812B1 (en) * | 2000-12-29 | 2003-04-15 | Advanced Cardiovascular Systems, Inc. | Radiation therapy using a radioactive implantable device and a radiosensitizer agent |
US20030004533A1 (en) * | 2001-05-04 | 2003-01-02 | Concentric Medical | Bioactive polymer vaso-occlusive device |
US20020193812A1 (en) * | 2001-05-04 | 2002-12-19 | Concentric Medical | Hydrogel vaso-occlusive device |
US20020187288A1 (en) | 2001-06-11 | 2002-12-12 | Advanced Cardiovascular Systems, Inc. | Medical device formed of silicone-polyurethane |
US6527938B2 (en) * | 2001-06-21 | 2003-03-04 | Syntheon, Llc | Method for microporous surface modification of implantable metallic medical articles |
US9861517B2 (en) * | 2001-07-26 | 2018-01-09 | Cook Medical Technologies Llc | Vessel closure member, delivery apparatus, and method of inserting the member |
US20030158598A1 (en) * | 2001-09-17 | 2003-08-21 | Control Delivery Systems, Inc. | System for sustained-release delivery of anti-inflammatory agents from a coated medical device |
WO2003035135A1 (en) * | 2001-09-24 | 2003-05-01 | Boston Scientific Limited | Optimized dosing for drug coated stents |
US6827737B2 (en) * | 2001-09-25 | 2004-12-07 | Scimed Life Systems, Inc. | EPTFE covering for endovascular prostheses and method of manufacture |
US6752826B2 (en) | 2001-12-14 | 2004-06-22 | Thoratec Corporation | Layered stent-graft and methods of making the same |
AU2003217329A1 (en) * | 2002-02-05 | 2003-09-02 | Thoratec Corporation | Coated vascular prosthesis and methods of manufacture and use. |
US6887270B2 (en) * | 2002-02-08 | 2005-05-03 | Boston Scientific Scimed, Inc. | Implantable or insertable medical device resistant to microbial growth and biofilm formation |
US7288111B1 (en) * | 2002-03-26 | 2007-10-30 | Thoratec Corporation | Flexible stent and method of making the same |
US20030199887A1 (en) * | 2002-04-23 | 2003-10-23 | David Ferrera | Filamentous embolization device and method of use |
WO2004006976A1 (en) * | 2002-07-12 | 2004-01-22 | Cook Incorporated | Coated medical device |
US20050013870A1 (en) * | 2003-07-17 | 2005-01-20 | Toby Freyman | Decellularized extracellular matrix of conditioned body tissues and uses thereof |
US20050090856A1 (en) * | 2003-10-27 | 2005-04-28 | Scimed Life Systems, Inc. | Vasco-occlusive devices with bioactive elements |
AU2004289362A1 (en) * | 2003-11-10 | 2005-05-26 | Angiotech International Ag | Intravascular devices and fibrosis-inducing agents |
JP4744863B2 (ja) * | 2003-12-17 | 2011-08-10 | コドマン・アンド・シャートレフ・インコーポレイテッド | 活性化可能で生体活性の移植可能な医療装置およびその使用方法 |
US20050137568A1 (en) * | 2003-12-17 | 2005-06-23 | Jones Donald K. | Activatable bioactive implantable medical device and method of use |
US20050220835A1 (en) * | 2004-03-30 | 2005-10-06 | Jayaraman Ramesh B | Agent eluting bioimplantable devices and polymer systems for their preparation |
US7244444B2 (en) * | 2004-03-31 | 2007-07-17 | Cook Incorporated | Graft material, stent graft and method |
US8007509B2 (en) * | 2005-10-12 | 2011-08-30 | Boston Scientific Scimed, Inc. | Coil assemblies, components and methods |
US11093759B2 (en) | 2018-03-06 | 2021-08-17 | Here Global B.V. | Automatic identification of roadside objects for localization |
-
2006
- 2006-09-28 US US11/529,872 patent/US20070082021A1/en not_active Abandoned
- 2006-09-28 AT AT06825153T patent/ATE536140T1/de active
- 2006-09-28 JP JP2008533552A patent/JP5063603B2/ja active Active
- 2006-09-28 EP EP06825153A patent/EP1931265B1/en active Active
- 2006-09-28 EP EP11161958A patent/EP2345376B1/en active Active
- 2006-09-28 WO PCT/US2006/037595 patent/WO2007041131A2/en active Application Filing
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2009509661A5 (ja) | ||
EP1931265B1 (en) | Coated vaso-occlusion device | |
JP4754573B2 (ja) | 外科的インプラント | |
CN101146484B (zh) | 用于永久性闭塞中空解剖结构的结构 | |
FI88460C (fi) | Aodertransplantat | |
US20090156711A1 (en) | Hemostatic device | |
US8063264B2 (en) | Hemostatic media | |
CN103974680B (zh) | 不粘附的伤口敷料及其相关方法 | |
KR20020003363A (ko) | 평면 형성물용 후크 앤 루프 탈부착 시스템 | |
JP2004515300A5 (ja) | ||
RU2015143893A (ru) | Хирургический имплантат | |
RU2011135753A (ru) | Приспособление для очистки ран | |
RU2008131328A (ru) | Гемостатическое изделие, содержащее адсорбент | |
CN113518633B (zh) | 包含复合生物纺织品的医学植入物组件和制造方法 | |
JPH09500802A (ja) | たて編ギプス包帯生地、たて編ギプス包帯および包帯の製造方法 | |
CN113490516B (zh) | 复合生物纺织品的制备方法以及包含复合生物纺织品的医学植入物 | |
WO2003070142A1 (fr) | Produit absorbant le fluide corporel et couche de bebe | |
KR20160099547A (ko) | 인공혈관 | |
JP2002020953A (ja) | 炭素繊維ネット状物 | |
ES2643662T3 (es) | Un hemóstato desplegable laparoscópicamente reabsorbible | |
JP2000265345A (ja) | パイル網地とその複合材および製造方法 | |
JP2019141500A (ja) | 自動縫合器用組織補強材 | |
JP7329384B2 (ja) | 組織再生基材 | |
JP2005102775A (ja) | おむつ | |
RU2670671C2 (ru) | Протез сосуда |